Loading viewer...
investor_presentation
Format: PDF investor_presentation
This document provides an overview of Atreca's corporate strategy and the potential of its immunotherapy products, highlighting future plans and research developments.
presentation
investor_presentation
44 Pages
Tonix Pharmaceuticals Holding Corp.